Pinguecula: Difference between revisions

No edit summary
No edit summary
 
(2 intermediate revisions by one other user not shown)
Line 10: Line 10:


==Clinical Features==
==Clinical Features==
[[File:PRE-OPERATIVE PINGUECULA.jpg|thumb|Pinguecula]]
*Triangular visible white-colored mass on the sclera
*Triangular visible white-colored mass on the sclera
*Foreign body sensation with irritation, pruritus, tearing, dryness
*Foreign body sensation with irritation, [[pruritus]], tearing, dryness
*Does not cross the limbus or enter the visual axis (Differentiates Pinguecula from a Pterygium)
*Does not cross the limbus or enter the visual axis (differentiates pinguecula from a [[pterygium]])


==Differential Diagnosis==
==Differential Diagnosis==
Line 23: Line 24:
*UV Protection
*UV Protection
*Lubricating eye drops
*Lubricating eye drops
*Naphazoline/ketorolac (NSAID) drops (if symptomatic)
*Naphazoline/ketorolac ([[NSAID]]) drops (if symptomatic)


==Disposition==
==Disposition==

Latest revision as of 21:35, 6 October 2019

Background

  • Benign scleral growth
    • Mass of collagen degeneration and fibroblastic proliferation
    • Can begin on the temporal or nasal side of the cornea. More commonly develops on the nasal side.

Risk factors

  • Sunlight (UV) exposure
  • Windy, sandy and dusty environments
  • More common near the equator

Clinical Features

Pinguecula
  • Triangular visible white-colored mass on the sclera
  • Foreign body sensation with irritation, pruritus, tearing, dryness
  • Does not cross the limbus or enter the visual axis (differentiates pinguecula from a pterygium)

Differential Diagnosis

Ocular Diagnoses

Evaluation

  • Clinical diagnosis, based on history and physical exam

Management

  • UV Protection
  • Lubricating eye drops
  • Naphazoline/ketorolac (NSAID) drops (if symptomatic)

Disposition

  • Discharge with non-emergent ophthalmology follow-up

See Also

References